27Serious

Semo Sititi

Semo Sititi

Ask VT AI

View News Summary

FDA issues draft guidance to streamline biosimilar approvals, aiming to cut bureaucracy and increase competition for lower-cost biologics.
GE HealthCare raises 2025 EPS forecast after strong Q3 results, with highlights including organic orders up 6% and robust capital-equipment demand.
Smurfit WestRock cuts full-year EBITDA forecast, citing weak North American demand and additional economic downtime in U.S. factories.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

FDA issues draft guidance to streamline biosimilar approvals, aiming to cut bureaucracy and increase competition for lower-cost biologics.
GE HealthCare raises 2025 EPS forecast after strong Q3 results, with highlights including organic orders up 6% and robust capital-equipment demand.
Smurfit WestRock cuts full-year EBITDA forecast, citing weak North American demand and additional economic downtime in U.S. factories.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Semo Sititi